Association of surgical strategy guided by Wu's classification with surgical outcomes in left-sided hepatocellular carcinoma patients with frailty.

Tianyang Mao, Dingxian Feng, Qingyun Xie, Xin Zhao, Hong Wu, Fengwei Gao, Ting Zhang

Abstract read

In one paragraph

Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tianyang Mao *Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Dingxian Feng *Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Qingyun XieLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Xin ZhaoLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

Hong WuLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. wuhong@scu.edu.cn.

Fengwei GaoLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. gaofengweigfw8@126.com.

Ting ZhangLaboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. tingzhang923@wchscu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrailty often indicates a poor prognosis after hepatectomy. This study aims to compare the short-term and long-term prognostic impacts of the Wu's classification group and the traditional group in treating left-sided hepatocellular carcinoma patients with frailty.

methodsThis retrospective cohort study analyzed 258 patients with left-sided hepatocellular carcinoma with frailty from 2009 to 2021, who were divided into a Wu's classification group and a traditional group based on surgical approach. Propensity score matching (PSM, 1:1) was used to minimize baseline differences and reduce selection bias. Perioperative outcomes, overall survival (OS), and recurrence-free survival (RFS) were evaluated. Kaplan-Meier survival analysis was performed to compare OS and RFS between the two groups, and Cox regression models were applied to identify independent prognostic factors.

resultsA total of 258 patients were included in the analysis cohort. Among them, 104 patients were assigned to the Wu's classification group, and 154 patients to the traditional group. After PSM, 186 patients were matched, with 93 patients in each group. The Wu's classification group demonstrated significantly lower intraoperative blood loss (P < 0.001), blood transfusion rate (P = 0.018), incidence of Clavien-Dindo grade ≥ 3 complications (P = 0.014), postoperative hospital stay (P < 0.001), and hospitalization costs (P = 0.035) compared with the traditional group. No significant difference in RFS was observed between the two groups, while the Wu's classification group demonstrated significantly higher OS (P = 0.004). Hospital frailty risk score (HR = 1.672, 95% CI 1.498-1.866, P < 0.001) were independent risk factors for OS.

conclusionsWu's classification-guided surgical strategy is associated with anatomical resection, less invasiveness, fewer postoperative complications, lower medical costs, and longer long-term survival among frail patients with left-sided HCC.

Indexed as

FrailtyHepatocellular carcinomaLeft liverSurgical strategy

Identifiers

PMID42839067

DOI10.1097/SLA.0000000000000882

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.